JGC
SAGE

J. Goldman & Co’s Sage Therapeutics SAGE Stock Holding History

J. Goldman & Co’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-116,842
Closed -$1.27M – 597
2024
Q2 		$1.27M Buy
+116,842
New +$1.5M 0.04% 287
2017
Q2 		– Sell
-9,300
Closed -$661K – 399
2017
Q1 		$661K Sell
9,300
-11,900
-56% -$697K 0.03% 270
2016
Q4 		$1.08M Sell
21,200
-29,400
-58% -$1.39M 0.07% 216
2016
Q3 		$2.33M Buy
50,600
+4,100
+9% +$167K 0.13% 170
2016
Q2 		$1.4M Sell
46,500
-55,500
-54% -$1.85M 0.07% 230
2016
Q1 		$3.27M Buy
+102,000
New +$3.59M 0.2% 136

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return